BeiGene | Study of BGB-A425 and LBL-007 in Combination With Tislelizumab in Advanced Solid Tumors

⟵ Back to Search Results

Study of BGB-A425 and LBL-007 in Combination with Tislelizumab in Advanced Solid Tumors

Beigene Study ID

BGB-900-102

ClinicalTrials.gov ID

NCT03744468

EudraCT Number

2022-500694-14

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents